Search results
Jun 20, 2024 · The Dangerous Drugs Board is committed to stamping out the illicit supply of and demand for dangerous drugs and precursor chemicals, and to promote regional and international cooperation in drug abuse prevention and control.
- About DDB
The drug problem was just at its incipient stage, with only...
- Preventive Education
DESCRIPTION: To bring the anti-drug advocacy to the...
- Legal Services
Treatment and rehabilitation of drug dependents is an...
- Issuances
Amending Section 3 (2) of Board Regulation No. 1, Series of...
- Mandate
The DDB envisions “Drug-Free Communities” Mission. The...
- Composition of the Board
The Dangerous Drugs Board is managed by a Board, a...
- Officials
The Dangerous Drugs Board is led by a Chairman with the rank...
- The DDB Secretariat
Training Section designs special trainings and conduct...
- About DDB
The Dangerous Drugs Board is managed by a Board, a multi-disciplinary body composed of 17 members, three of whom are Permanent, 12 are Ex-Officio and two are Regular Members. The President of the Republic of the Philippines decides from among the three Permanent Members who will hold the position of Chairman with the rank of a Secretary.
The Dangerous Drugs Board is led by a Chairman with the rank of Secretary and two Permanent Board Members with the rank of Undersecretary.
Amending Section 3 (2) of Board Regulation No. 1, Series of 2014 and Creating the Committee on Reclassification, Addition or Removal of any Drug/Substance from the List of Dangerous Drugs/Controlled Precursors and Essential Chemicals
Dangerous Drugs Board (Main Office) Tel. No.: +632 8929-45-44 and +632 8929-17-53. 3rd Floor DDB-PDEA Bldg., National Government Center, NIA Road, Brgy. Pinyahan, Quezon City, NCR, 1100, Philippines. info@ddb.gov.ph
The Dangerous Drugs Board (DDB) is a government agency tasked in creating policies and programs in addressing the country’s illegal drug problem.
Online Application for Certification and Exemption Information System. Email Address. Login. Clear. OR.